Olympus Corporation

06/19/2026

At Olympus, our commitment to putting patients first includes working with cancer societies worldwide. We recently partnered with the Korean Cancer Society to host the 'Going-on Walk' during Cancer Surivors Week in Korea, bringing together cancer survivors, their families, and Olympus employees to connect and give back.

Key highlights from the event include:
🔹100+ Participants: Cancer survivors, families, and Olympus Korea volunteers
🔹382 kg of Marine Waste Collected: Cleared the coastline at Masian Beach in Yeongjongdo ahead of World Environment Day
🔹Meaningful Connections: Participants shared powerful stories of recovery and mutual support
🔹Creative Outlets: Activities included upcycling workshops using sea glass

We extend our heartfelt gratitude to everyone who participated in this event and who continue to help us create a more supportive world for cancer survivors.💙

06/18/2026

Olympus is pushing the future of GI care forward with robotic innovation.

In a recent interview with MedTech Dive, Keith Boettiger, head of Olympus’ GI solutions division, shared how we're combining long-term innovation with near-term solutions to expand access to advanced procedures.

Why it matters:
• Colorectal cancer continues to rise globally
• Complex procedures for lesion treatment are difficult to master and underutilized
• Robotics can make these procedures easier, safer, and more accessible

Read more about our goal to help doctors detect, diagnose, and treat in a single visit while reducing the need for invasive surgery:

Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.

05/26/2026

Olympus has signed a definitive agreement to acquire BioProtect, a medical device manufacturer that develops implant technologies designed to help improve prostate cancer care and enhance patients’ quality of life. By providing consistent and controllable spacing between the prostate and other critical structures, their technologies help patients preserve gastrointestinal, urinary and sexual functions during and after treatment.

This acquisition marks an important expansion of Olympus’ contributions to oncology and urology in line with its corporate strategy to accelerate innovative technologies and focus on patient safety and outcomes.

With prostate cancer being the second most diagnosed form of cancer among men worldwide, this acquisition underscores our commitment to addressing unmet medical needs in cancer care.

🔗 Learn more here: https://www.olympus-global.com/news/2026/nr03020.html

05/04/2026

We’re excited to announce a new global distribution agreement between Olympus and EndoRobotics.

By adding robot-assisted technologies to our EndoTherapy portfolio, we’re working to expand patient access to minimally invasive endoscopic procedures in an effort to support safe, effective GI care.

👉 Learn more: http://spkl.io/6182AAbcy

04/15/2026

Olympus recientemente organizó Japan Meets LATAM en Bogotá, Colombia, presentando el sistema de endoscopia EVIS X1™ y los endoscopios EZ1500 con tecnología EDOF™. La visualización mejorada y la profundidad de campo extendida continúan elevando la precisión y la confianza en la endoscopia avanzada.

04/08/2026

Únase a Japan Meets LATAM – Vol. 5, donde el Dr. Mineo Iwatate y el Dr. Pedro Larrea compartirán su experiencia sobre cómo la tecnología EDOF™ permite una visualización mejorada y mayor precisión en los procedimientos.

Regístrese aquí: http://spkl.io/6182A2l7n

04/01/2026

Olympus announced a leadership transition in the Americas effective April 1, 2026, as part of its new global operating model. Richard Reynolds has been appointed Regional President, bringing decades of global experience to support Olympus’ continued innovation in endoscopy-enabled care. http://spkl.io/6187AFahH

04/01/2026

Exciting news – Olympus has appointed three new executive officers, effective April 1, 2026!

Simone brings extensive global HR transformation experience, David offers decades of leadership in global operations and supply chain, and Michael brings a strong financial leadership background across global MedTech and healthcare organizations.

Together, they will help guide our ongoing evolution towards being a truly global MedTech company.

Learn more about our new CFO: http://spkl.io/6187A0fhx
Learn more about our new CHRO & CMSO: http://spkl.io/6188A0fhI

03/31/2026

Exciting news! Olympus Corporation of the Americas is proud to be recognized as a Military and Military Spouse-Friendly workplace for 2026! Supporting our employees is our top priority. http://spkl.io/6187AFo3P

03/31/2026

With a deep family history of colorectal cancer, David has long been an advocate for regular screenings. As a Senior Product Manager at Olympus, he’s proud to work on the very technology that plays a critical role in the treatment of the disease.

His story highlights the powerful combination of personal experience and professional commitment that drives innovation and excellence at Olympus. colonoscopytoday.com